Maria Lummerstorfer

Maria Lummerstorfer is a researcher at the Department of Pharmaceutical Sciences within the Faculty of Life Sciences, holding a Magister (Mag.) degree equivalent to a Master's and a Bachelor of Science (BSc) credential. Her academic profile centers on pharmaceutical research with emphasis on innovative therapeutic delivery systems addressing critical medical challenges.

Her research specializes in nanomedicine applications for infectious disease treatment, particularly developing human serum albumin nanoparticles as precision vehicles for antibiotic delivery to combat bacterial infections and overcome antimicrobial resistance. This work bridges pharmaceutical sciences and nanotechnology to enhance drug targeting while minimizing systemic side effects, with implications for treating urinary tract infections and other resistant bacterial conditions.

Analysis of her 2023 publication reveals a strategic focus on translating nanocarrier technology into clinical solutions for antibiotic resistance. Her research trajectory demonstrates consistent advancement in nanoparticle engineering for targeted therapy, with growing collaboration networks evident in co-authorship patterns and conference participation through 2025, indicating sustained contributions to pharmaceutical innovation.